应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02096 先声药业
已收盘 03-10 16:08:49
11.970
+0.320
+2.75%
最高
12.100
最低
11.750
成交量
475.76万
今开
11.750
昨收
11.650
日振幅
3.00%
总市值
310.74亿
流通市值
310.74亿
总股本
25.96亿
成交额
5,691万
换手率
0.18%
流通股本
25.96亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
先声药业(02096)更新2月股份变动月报表,股本维持稳定
公告速递 · 03-04
先声药业(02096)更新2月股份变动月报表,股本维持稳定
每日卖空追踪 | 先声药业 03月04日卖空量成交17.9万股,卖空比例为3.42%
市场透视 · 03-04
每日卖空追踪 | 先声药业 03月04日卖空量成交17.9万股,卖空比例为3.42%
先声药业03月04日遭主力抛售262.4万元
市场透视 · 03-04
先声药业03月04日遭主力抛售262.4万元
业绩持续亏损!先声再明拟赴港上市,股权变动等被要求补充说明
深圳商报·读创 · 03-03
业绩持续亏损!先声再明拟赴港上市,股权变动等被要求补充说明
每日卖空追踪 | 先声药业 03月02日卖空量成交31万股,卖空比例为4.85%
市场透视 · 03-02
每日卖空追踪 | 先声药业 03月02日卖空量成交31万股,卖空比例为4.85%
先声药业03月02日遭主力抛售210.2万元
市场透视 · 03-02
先声药业03月02日遭主力抛售210.2万元
BD成药企业绩增长新引擎,涉及先声药业、三生国健、荣昌生物等
动脉网 · 02-27
BD成药企业绩增长新引擎,涉及先声药业、三生国健、荣昌生物等
每日卖空追踪 | 先声药业 02月26日卖空量成交61.9万股,卖空比例为5.57%
市场透视 · 02-26
每日卖空追踪 | 先声药业 02月26日卖空量成交61.9万股,卖空比例为5.57%
盈喜预告接连发布:BD成估值新锚,药企加速跨越生死线
21世纪经济报道 · 02-26
盈喜预告接连发布:BD成估值新锚,药企加速跨越生死线
先声药业盘中异动 股价大跌5.00%报12.350港元
市场透视 · 02-26
先声药业盘中异动 股价大跌5.00%报12.350港元
先声药业(02096)预期2025财年股东应占利润约13亿元至14亿元 同比增长约80.1%至93.9%
智通财经 · 02-25
先声药业(02096)预期2025财年股东应占利润约13亿元至14亿元 同比增长约80.1%至93.9%
每日卖空追踪 | 先声药业 02月24日卖空量成交40.9万股,卖空比例为9.19%
市场透视 · 02-24
每日卖空追踪 | 先声药业 02月24日卖空量成交40.9万股,卖空比例为9.19%
争分夺秒,“药”与时间赛跑
金陵晚报 · 02-24
争分夺秒,“药”与时间赛跑
先声药业02月23日获主力加仓103.8万元
市场透视 · 02-23
先声药业02月23日获主力加仓103.8万元
蛋白降解(TPD):26年看自免管线临床突破
华福证券 · 02-23
蛋白降解(TPD):26年看自免管线临床突破
每日卖空追踪 | 先声药业 02月16日卖空量成交6.1万股,卖空比例为34.66%
市场透视 · 02-16
每日卖空追踪 | 先声药业 02月16日卖空量成交6.1万股,卖空比例为34.66%
先声药业早盘涨逾3% 国金证券维持“买入”评级
新浪港股 · 02-13
先声药业早盘涨逾3% 国金证券维持“买入”评级
港股异动 | 先声药业(02096)涨超3% 近日核心产品SIM0500获艾伯维4000万美元里程碑付款
智通财经 · 02-13
港股异动 | 先声药业(02096)涨超3% 近日核心产品SIM0500获艾伯维4000万美元里程碑付款
每日卖空追踪 | 先声药业 02月12日卖空量成交6.4万股,卖空比例为1.38%
市场透视 · 02-12
每日卖空追踪 | 先声药业 02月12日卖空量成交6.4万股,卖空比例为1.38%
先声药业02月11日获主力加仓368.4万元
市场透视 · 02-11
先声药业02月11日获主力加仓368.4万元
加载更多
公司概况
公司名称:
先声药业
所属市场:
SEHK
上市日期:
--
主营业务:
先声药业集团有限公司是一家从事药品的研发、生产和销售的公司。该公司的主要产品为仿制药,包括用于中枢神经系统疾病的产品必存、用于肿瘤疾病的产品捷百舒和捷佰立、以及用于自身免疫疾病的产品英太青。该公司还从事生产创新药,比如用于肿瘤疾病的恩度。该公司还从事为医疗机构销售的第三方药品提供推广服务。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02096","market":"HK","secType":"STK","nameCN":"先声药业","latestPrice":11.97,"timestamp":1773130129004,"preClose":11.65,"halted":0,"volume":4757580,"delay":0,"changeRate":0.027467811158798306,"floatShares":2596000000,"shares":2596000000,"eps":0.3298188703455937,"marketStatus":"已收盘","change":0.32,"latestTime":"03-10 16:08:49","open":11.75,"high":12.1,"low":11.75,"amount":56913021,"amplitude":0.030043,"askPrice":11.97,"askSize":7000,"bidPrice":11.96,"bidSize":24000,"shortable":3,"etf":0,"ttmEps":0.42307799920193406,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773192600000},"marketStatusCode":5,"adr":0,"listingDate":1603728000000,"exchange":"SEHK","adjPreClose":11.65,"dividendRate":0.014603,"openAndCloseTimeList":[[1773106200000,1773115200000],[1773118800000,1773129600000]],"volumeRatio":0.768972,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02096","defaultTab":"news","newsList":[{"id":"1175955561","title":"先声药业(02096)更新2月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1175955561","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175955561?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:52","pubTimestamp":1772614349,"startTime":"0","endTime":"0","summary":"先声药业集团有限公司于2026年3月4日披露2026年2月股份变动月报表。截至2026年2月28日,公司已发行股份总数为2,595,697,618股,与上月底保持一致,未有新增发行、回购注销或库藏股变动。报告期内普通股的已发行股份数量连续保持2,595,697,618股,库存股份数量维持0股,公司确认符合最低15.45%的上市时公众持股量要求。公司声明按照香港联交所《上市规则》及相关法律规范维持充足公众持股量。截至2月末,股本总数稳定,公司股本结构无实质性变化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"gpt_icon":0},{"id":"2617972325","title":"每日卖空追踪 | 先声药业 03月04日卖空量成交17.9万股,卖空比例为3.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617972325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617972325?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613027,"startTime":"0","endTime":"0","summary":"先声药业北京时间03月04日,跌1.99%,卖空量成交17.9万股,较上一交易日减少65.04%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163341a6a14e69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163341a6a14e69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"2617597253","title":"先声药业03月04日遭主力抛售262.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617597253","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617597253?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612137,"startTime":"0","endTime":"0","summary":"03月04日, 先声药业股价跌1.99%,报收11.33元,成交金额5950.7万元,换手率0.20%,振幅4.07%,量比0.67。先声药业今日主力资金净流出262.4万元,连续4日净流出,上一交易日主力净流出985.7万元。该股近5个交易日下跌13.54%,主力资金累计净流出969.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1853.8万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161742a6a13c90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161742a6a13c90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"2616763313","title":"业绩持续亏损!先声再明拟赴港上市,股权变动等被要求补充说明","url":"https://stock-news.laohu8.com/highlight/detail?id=2616763313","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616763313?lang=zh_cn&edition=full","pubTime":"2026-03-03 14:19","pubTimestamp":1772518741,"startTime":"0","endTime":"0","summary":"日前,据中国证监会官网,先声再明医药股份有限公司(下称“先声再明”)被要求补充说明历次增资及股权转让、是否存在股份代持情形、经营范围及实际业务相关情况等。招股书介绍,先声再明为一家处于全球药物创新前沿的生物制药企业,聚焦于肿瘤创新药物的研究、开发与商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603033660178447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2616369690","title":"每日卖空追踪 | 先声药业 03月02日卖空量成交31万股,卖空比例为4.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616369690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616369690?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440230,"startTime":"0","endTime":"0","summary":"先声药业北京时间03月02日,跌4.6%,卖空量成交31万股,较上一交易日减少76.01%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163408a730c6b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163408a730c6b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2616369657","title":"先声药业03月02日遭主力抛售210.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616369657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616369657?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:16","pubTimestamp":1772439366,"startTime":"0","endTime":"0","summary":"03月02日, 先声药业股价跌4.60%,报收11.83元,成交金额7603.7万元,换手率0.25%,振幅4.44%,量比0.98。先声药业今日主力资金净流出210.2万元,上一交易日主力净流出234.9万元。该股近5个交易日下跌10.11%,主力资金累计净流入839.7万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入3007.5万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302162439a730b912&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302162439a730b912&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2614891101","title":"BD成药企业绩增长新引擎,涉及先声药业、三生国健、荣昌生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2614891101","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614891101?lang=zh_cn&edition=full","pubTime":"2026-02-27 14:56","pubTimestamp":1772175360,"startTime":"0","endTime":"0","summary":"随着全球医药产业的迭代升级,中国创新药企如先声药业、三生国健和荣昌生物等正通过BD交易加速业绩增长。先声药业预计2025年收入约77-78亿元,同比增长16.0%-17.6%,主要得益于创新药收入和对外授权许可收入的增加。三生国健2025年营业收入同比增加251.81%至41.99亿元,净利润同比增加317.09%至29.39亿元,主要归因于与辉瑞的合作。荣昌生物也预计全年实现营业收入约32.5亿元,BD同样起到重要作用。这些案例表明,BD已成为中国创新药企业绩增长的新引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227151826a725a194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227151826a725a194&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","BK1583","LU2328871848.SGD","02096","BK1574","BK1161","LU1969619763.USD","BK1191"],"gpt_icon":0},{"id":"2614859003","title":"每日卖空追踪 | 先声药业 02月26日卖空量成交61.9万股,卖空比例为5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614859003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614859003?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:30","pubTimestamp":1772094627,"startTime":"0","endTime":"0","summary":"先声药业北京时间02月26日,跌7.54%,卖空量成交61.9万股,较上一交易日减少7.47%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163353a7219aa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163353a7219aa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2614091923","title":"盈喜预告接连发布:BD成估值新锚,药企加速跨越生死线","url":"https://stock-news.laohu8.com/highlight/detail?id=2614091923","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614091923?lang=zh_cn&edition=full","pubTime":"2026-02-26 14:29","pubTimestamp":1772087394,"startTime":"0","endTime":"0","summary":"2月25日,先声药业发布盈喜预告。预告显示,2025财政年度公司预计录得收入约人民币77亿至78亿元,同比增长16.0%至17.6%;而归属于公司权益股东的利润更是有望达到人民币13亿至14亿元,同比增幅高达80.1%至93.9%。在医药行业整体仍在调整期中艰难跋涉的背景下,这份接近翻倍的利润增长答卷显得尤为耀眼。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602263655228925.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602263655228925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","BK1191","02096","BK1583","02615","BMS","06978"],"gpt_icon":0},{"id":"2614003837","title":"先声药业盘中异动 股价大跌5.00%报12.350港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614003837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614003837?lang=zh_cn&edition=full","pubTime":"2026-02-26 11:47","pubTimestamp":1772077668,"startTime":"0","endTime":"0","summary":"2026年02月26日临近午盘11时47分,先声药业股票出现波动,股价大幅下挫5.00%。截至发稿,该股报12.350港元/股,成交量662.871万股,换手率0.26%,振幅6.23%。资金方面,该股资金流入3444.17万港元,流出3790.98万港元。先声药业股票所在的药品行业中,整体跌幅为0.86%。其相关个股中,泰德医药、泰凌医药、长风药业涨幅较大,振幅较大的相关个股有宝济药业-B、德琪医药-B、九源基因,振幅分别为15.95%、10.16%、8.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022611474895420989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022611474895420989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"2614024817","title":"先声药业(02096)预期2025财年股东应占利润约13亿元至14亿元 同比增长约80.1%至93.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614024817","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614024817?lang=zh_cn&edition=full","pubTime":"2026-02-25 17:23","pubTimestamp":1772011423,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先声药业 发布公告,根据对截至2025年12月31日止年度集团的未经审核综合管理账目的初步评估,预期如下:集团于2025年财政年度将取得收入约人民币77亿元至人民币78亿元,相比于截至2024年12月31日止年度的收入约人民币66.35亿元增幅约16.0%至17.6%。集团于2025年财政年度将取得归属于公司权益股东的利润约人民币13亿元至人民币14亿元,相比于2024年财政年度的经重述归属于公司权益股东的利润约人民币7.22亿元增幅约80.1%至93.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02096","BK1191"],"gpt_icon":0},{"id":"2613571856","title":"每日卖空追踪 | 先声药业 02月24日卖空量成交40.9万股,卖空比例为9.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613571856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613571856?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921826,"startTime":"0","endTime":"0","summary":"先声药业北京时间02月24日,跌0.54%,卖空量成交40.9万股,较上一交易日减少19.49%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163355a4c2353b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163355a4c2353b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2613549718","title":"争分夺秒,“药”与时间赛跑","url":"https://stock-news.laohu8.com/highlight/detail?id=2613549718","media":"金陵晚报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613549718?lang=zh_cn&edition=full","pubTime":"2026-02-24 00:00","pubTimestamp":1771862400,"startTime":"0","endTime":"0","summary":"去年7月,国产抗血管生成靶向一类新药注射用苏维西塔单抗获批上市,并在同年进入国家医保,今年1月1日起执行。“化疗耐药后,患者生存期通常不足一年。”口罩后面,于宏伟眼里透出的笑意很暖,“市场有需求,患者在等待。我们得提前生产,以防患者需要用药的时候供不上。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224021219a4bfbaf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224021219a4bfbaf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02096","BK1191"],"gpt_icon":0},{"id":"2613878177","title":"先声药业02月23日获主力加仓103.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613878177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613878177?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:16","pubTimestamp":1771834562,"startTime":"0","endTime":"0","summary":"02月23日, 先声药业股价涨2.76%,报收13.05元,成交金额2155.8万元,换手率0.06%,振幅1.97%,量比0.42。先声药业今日主力资金净流入103.8万元,上一交易日主力净流入23.7万元。该股近5个交易日上涨3.39%,主力资金累计净流入1064.9万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2402.6万元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162118a7155c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162118a7155c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2613781173","title":"蛋白降解(TPD):26年看自免管线临床突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2613781173","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613781173?lang=zh_cn&edition=full","pubTime":"2026-02-23 00:00","pubTimestamp":1771776000,"startTime":"0","endTime":"0","summary":"本周涨幅前五的个股为:振德医疗、欧林生物、美好医疗、万泽股份、博拓生物TPD 赛道研发火热,26 年重点关注自免管线临床进展。蛋白降解技术在自身免疫疾病进展迅速,STAT6、IRAK4、IRF5、VAV1、NLRP3、NEK7 等热门小分子靶点备受关注。2026 年开始,众多自免TPD 靶点将迎来数据读出,或进入到临床关键性阶段,值得重点关注。国内公司中,苑东生物、诺诚健华均有VAV1 分子胶产品布局,海思科、先声药业均有STAT6 靶点布局,百济神州亦有IRAK4 靶点布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223171634a7157e24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223171634a7157e24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1303224171.USD","09939","BK1500","BK1583","BK1161","02096","HK0000252152.HKD","BK1588","LU1969619763.USD","HK0000500386.USD","LU1251922891.USD","BK1574","06160","HK0000252160.HKD","LU2328871848.SGD","LU0588546209.SGD","LU1770034418.SGD","LU1719994722.HKD","LU0307460666.USD","09606","LU2543165471.USD","BK1515"],"gpt_icon":0},{"id":"2611948875","title":"每日卖空追踪 | 先声药业 02月16日卖空量成交6.1万股,卖空比例为34.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611948875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611948875?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230624,"startTime":"0","endTime":"0","summary":"先声药业北京时间02月16日,跌2.25%,卖空量成交6.1万股,较上一交易日减少91.76%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163308a700decf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163308a700decf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"2611183503","title":"先声药业早盘涨逾3% 国金证券维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2611183503","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611183503?lang=zh_cn&edition=full","pubTime":"2026-02-13 10:48","pubTimestamp":1770950880,"startTime":"0","endTime":"0","summary":" 先声药业盘中涨超3%,截至发稿,股价上涨2.93%,报12.64港元,成交额2372.23万港元。 近日,先声药业发布公告,内容有关集团附属公司已与AbbVie Inc. 附属公司就研究性新候选药物SIM0500订立海外许可选择权协议。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-13/doc-inhmrtii9016929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02096"],"gpt_icon":0},{"id":"2611183352","title":"港股异动 | 先声药业(02096)涨超3% 近日核心产品SIM0500获艾伯维4000万美元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2611183352","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611183352?lang=zh_cn&edition=full","pubTime":"2026-02-13 10:40","pubTimestamp":1770950408,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,先声药业涨超3%,截至发稿,涨2.69%,报12.61港元,成交额2201.87万港元。消息面上,近日,先声药业发布公告,内容有关集团附属公司已与AbbVie Inc. 附属公司就研究性新候选药物SIM0500订立海外许可选择权协议。华泰证券指出,先声药业核心产品SIM0500获得艾伯维4000万美元里程碑付款,该BCMA/GPRC5D/CD3三抗TCE已获FDA快速通道认定,预计年内读出I期临床数据并实现概念验证。SIM0500在临床前研究中显示出显著优于双抗TCE的抗肿瘤活性,同靶点组合竞品中全球进度领先。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405014.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","VXUS","BK4588","BK1583","BK1191","VT","BK4585"],"gpt_icon":0},{"id":"2610450019","title":"每日卖空追踪 | 先声药业 02月12日卖空量成交6.4万股,卖空比例为1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610450019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610450019?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:30","pubTimestamp":1770885027,"startTime":"0","endTime":"0","summary":"先声药业北京时间02月12日,跌3.08%,卖空量成交6.4万股,较上一交易日减少88.1%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163334a49b9ee9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163334a49b9ee9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2610999433","title":"先声药业02月11日获主力加仓368.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610999433","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610999433?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:15","pubTimestamp":1770797708,"startTime":"0","endTime":"0","summary":"02月11日, 先声药业股价涨2.18%,报收12.67元,成交金额5438.3万元,换手率0.17%,振幅3.23%,量比0.66。先声药业今日主力资金净流入368.4万元,连续3日净流入,上一交易日主力净流入983.9万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为81.25%,平均涨幅为3.06%。该股近5个交易日上涨8.65%,主力资金累计净流入1546.4万元;近20日主力资金累计净流入2845.1万元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161519a4971a88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161519a4971a88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02096","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.simcere.com","stockEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.1558},{"period":"6month","weight":-0.1588},{"period":"1year","weight":0.4841},{"period":"ytd","weight":-0.0267}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0434},{"period":"3month","weight":-0.001},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.0486},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先声药业集团有限公司是一家从事药品的研发、生产和销售的公司。该公司的主要产品为仿制药,包括用于中枢神经系统疾病的产品必存、用于肿瘤疾病的产品捷百舒和捷佰立、以及用于自身免疫疾病的产品英太青。该公司还从事生产创新药,比如用于肿瘤疾病的恩度。该公司还从事为医疗机构销售的第三方药品提供推广服务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.093182},{"month":2,"riseRate":0.666667,"avgChangeRate":0.070781},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.028184},{"month":4,"riseRate":0.6,"avgChangeRate":0.009116},{"month":5,"riseRate":0.8,"avgChangeRate":0.158743},{"month":6,"riseRate":0.6,"avgChangeRate":0.036684},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0521},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05132},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0324},{"month":10,"riseRate":0.8,"avgChangeRate":0.108781},{"month":11,"riseRate":0.666667,"avgChangeRate":0.044275},{"month":12,"riseRate":0.5,"avgChangeRate":0.000552}],"exchange":"SEHK","name":"先声药业","nameEN":"SIMCERE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先声药业,02096,先声药业股票,先声药业股票老虎,先声药业股票老虎国际,先声药业行情,先声药业股票行情,先声药业股价,先声药业股市,先声药业股票价格,先声药业股票交易,先声药业股票购买,先声药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}